Cargando…

MGBG–cisplatin combination chemotherapy against breast cancer

Detalles Bibliográficos
Autores principales:	Gonsalves, Raquel F, Marques, Maria PM
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3255023/

Ejemplares similares

Melanoma skin cancer: could chromone derivatives be efficient chemopreventors?
por: Dias, Mafalda M, et al.
Publicado: (2010)

Reduced MCPH1 expression in breast cancer and response to chemotherapy
por: Richardson, J, et al.
Publicado: (2010)

Cancer chemotherapy: early experience with combined chemotherapy for HIV-infected Kaposi's sarcoma patients at Lighthouse clinic, Lilongwe, Malawi
por: Mulinde, HF, et al.
Publicado: (2010)

The effect of cisplatin in 5637 bladder cancer cell line
por: Pinto-Leite, Rosário, et al.
Publicado: (2010)

Regulation of cytochrome P450s in breast cancer and their role for tumour growth and anticancer chemotherapy
por: Friedberg, T, et al.
Publicado: (2006)

Correlation of post-neoadjuvant chemotherapy response on MRI with final histology in breast cancer patients
por: Mahatma, Anjum, et al.
Publicado: (2015)

Accuracy of MRI for prediction of response to neo-adjuvant chemotherapy in triple negative breast cancer
por: Bansal, GJ, et al.
Publicado: (2015)

An immune surveillance model to monitor the response to neo-adjuvant chemotherapy treatment in breast cancer patients
por: Bernal-Estévez, David A, et al.
Publicado: (2015)

Nanoparticulate paclitaxel loaded into sterically stabilized mixed phospholipid micelles to improve chemotherapy of breast cancer
por: Rubinstein, I, et al.
Publicado: (2005)

Fucosylation enhances activity of cytotoxic T lymphocytes against breast cancer
por: Qiao, Na, et al.
Publicado: (2015)

Transcriptome profile of OVCAR3 cisplatin-resistant ovarian cancer cell line
por: Sakhare, Shruti S, et al.
Publicado: (2014)

Insulin-like growth factor binding protein-2 alters the sensitivity of breast cancer cells to chemotherapy
por: Foulstone, EJ, et al.
Publicado: (2010)

Topoisomerase 2 alpha as a predictor of response to anthracycline neoadjuvant chemotherapy in locally advanced breast cancer
por: Shehata, M, et al.
Publicado: (2010)

Monitoring of minimal residual cancer in bone marrow in high-risk breast cancer patients treated with high-dose chemotherapy
por: Drageset, V, et al.
Publicado: (2005)

Obesity and breast cancer: inflammatory and adipocytokine correlations
por: Matafome, Paulo C, et al.
Publicado: (2010)

Efficacy and safety of the administration of bevacizumab in combination with first-line chemotherapy for the treatment of advanced breast carcinoma: ATHENA MO19391 study results in Spanish patients
por: Ciruelos, EM, et al.
Publicado: (2009)

PB.03: Evaluating the role of breast MRI at mid-cycle chemotherapy
por: Santosh, D, et al.
Publicado: (2013)

Imaging the breast following neoadjuvant chemotherapy: does improvement of imaging findings in the axilla predict pathological response in the breast?
por: Williams, A, et al.
Publicado: (2012)

Use of MRI to predict response following neoadjuvant chemotherapy for breast cancer: how accurately can it guide surgical choice?
por: Tan, Sue, et al.
Publicado: (2015)

Differentiation therapy: targeting breast cancer stem cells to reduce resistance to radiotherapy and chemotherapy
por: Roy, R, et al.
Publicado: (2010)

Preclinical evaluation of MVA-MUC1-IL2 in combination with chemotherapy in murine models
por: De Meyer, Micaël, et al.
Publicado: (2013)

Epidemiological changes in premenopausal patients with breast cancer: a two-decade retrospective study
por: Garcia-Faura, A, et al.
Publicado: (2009)

Contemporary breast cancer chemotherapy leads to persistent late right ventricular myocardial dysfunction: a prospective multi-centre study
por: Grover, Suchi, et al.
Publicado: (2013)

Study of circulating myeloid derived suppressor cells (MDSC) in patients with breast cancer undergoing neo-adjuvant chemotherapy; interim results
por: Wesolowski, Robert, et al.
Publicado: (2013)

ANP/GC-A signaling attenuates tissue injury by cisplatin
por: Nojiri, Takashi, et al.
Publicado: (2013)

AB118. Effect of MOTILIPERM in cisplatin administered SD rats
por: Soni, Kiran Kumar, et al.
Publicado: (2016)

PB.34. Marker clip placement may not be needed in breast cancer patients undergoing neoadjuvant chemotherapy with a view to breast-conserving surgery whose tumours are associated with microcalcification
por: Sreenivas, M
Publicado: (2014)

Impact of chemotherapy alone, and chemotherapy plus ipilimumab, on circulating immune cells in patients with metastatic bladder cancer
por: Galsky, Matthew D, et al.
Publicado: (2015)

Combination of variability with pressure support ventilation enhances lung protection and function in experimental acute lung injury
por: de Abreu, M Gama, et al.
Publicado: (2009)

Use of ultrasound elasticity imaging to monitor the response of a primary breast cancer to neoadjuvant chemotherapy in one patient in a pilot study
por: English, RE, et al.
Publicado: (2011)

Early and late left ventricular effects of breast cancer chemotherapy: a prospective multi-centre study using advanced cardiac imaging
por: Grover, Suchi, et al.
Publicado: (2013)

Indentification of cancer stem-like cells in osteosarcoma and their implications in response to chemotherapy
por: Lopes, Áurio O, et al.
Publicado: (2010)

Effective use of rituximab in combination with low dose cyclophosphamide in childhood onset systemic lupus erythematosus (SLE) with relapsing class IV nephritis
por: Miettunen, PM, et al.
Publicado: (2008)

Identification of proteins and signalling pathways involved in neoadjuvant chemotherapy responsiveness of breast tumours using proteomics
por: Greenwood, CR, et al.
Publicado: (2010)

PB.32. Type of breast surgery in patients undergoing neoadjuvant chemotherapy: role of DCE-MRI
por: Halim, M, et al.
Publicado: (2014)

Phase I study of combination therapy with weekly paclitaxel and cyclophosphatamide for advanced or recurrent breast cancer
por: Nakayama, T, et al.
Publicado: (2009)

P071 Actigraphy-Derived Rest-Activity Rhythms Predict Sleep-Related Self-Report Outcomes in Women Receiving Chemotherapy for Breast Cancer
por: Maccora, J, et al.
Publicado: (2022)

AB058. Intravenous chemotherapy combined with intravesical chemotherapy to treat T1G3 bladder urothelial carcinoma after transurethral resection of bladder tumor: results of a retrospective study
por: Zhang, Yu, et al.
Publicado: (2016)

Metabolic responses of A549 lung cells to cisplatin and radiation exposure studied by (1)H NMR spectroscopy
por: Ladeirinha, Ana F, et al.
Publicado: (2010)

Early cardiac changes following anthracycline chemotherapy in breast cancer: a prospective multi-centre study using advanced cardiac imaging and biochemical markers
por: Grover, Suchi, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_vfu7900flks12une0qorcbljbo